What is the future for global case management guidelines for common childhoom diseases?

PLoS Medicine

Volumn 5, Issue 12, 2008, Pages 1665-1669

  English, Mike ^a,b   Scott, J Anthony G ^a,c  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b Department of Paediatrics ^*

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; PNEUMOCOCCUS VACCINE;

ASTHMA; BACTERIAL PNEUMONIA; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL DECISION MAKING; DIAGNOSTIC PROCEDURE; FUTUROLOGY; HAEMOPHILUS INFLUENZAE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH SURVEY; INCIDENCE; INTERVENTION STUDY; LOWEST INCOME GROUP; MALARIA; PATIENT COMPLIANCE; PRACTICE GUIDELINE; REVIEW; RISK REDUCTION; TECHNOLOGY; VACCINATION; ALGORITHM; ARTICLE; CHILD; CONSENSUS; FORECASTING; HISTORY; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PEDIATRICS; THERAPY; WORLD HEALTH ORGANIZATION;

ALGORITHMS; CHILD; CONSENSUS; FORECASTING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; THERAPEUTICS; WORLD HEALTH ORGANIZATION;

EID: 58149470258     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050241     Document Type: Review

References (24)

1. Darmstadt G, Bhutta Z, Cousens S, Adam T, Walker N, et al. (2005) Evidence-based, cost-effective intervention: How many newborn babies can we save? Lancet 365: 977-988.
2. Jones G, Steketee RW, Black RE. Bhutta ZA, Morris SS, et al. (2003) How many child deaths can we prevent this year? Lancet 362: 03-71.
3. Greenwood B, Weber M, Mulholland K (2007) (Childhood pneumonia-Preventing the world's biggest killer of children. Bull World Health Organ 85: 502-503.
4. Oxman AD, Lavis JN, Fretheim A (2007) Use of evidence in WHO recommendations. Lancet 369: 1883-1869.
5. Bhattarai A, Ali AS, Kachur SP Mårtensson A. Abbas AK, et al. (2007) Impact of artemisininbased combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 4:e309. doi:10.1371/journal. pmed. 0040309
6. Fegan GW, Noor AM, Akhwale Ws, Cousens S, Snow RW (2007) Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: A longitudinal study. Lancet 307: 10351039,
7. Cowgill KD, Ndiritu M, Nyiro J, Slack MP, Chiphatsi S, et al. (2006) Effectiveness of hacmophilus Influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 296:671-678.
8. Cutts F, Zaman S, Enwere G, Jaffar S, Levine O, et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Garmbia: Ransornised, double-blind, Placebo-controlled trial. Lancet 365: 1139-1146.
9. Scott JAG, English M (2008) What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal baccines in developing countries? PLoS Med 5: e86. doi:10.1371/journal.pmed.0050086
10. Adams O, Dal Poz M, Shengelia D, Kwankam S, Issakov A, et al. (2003) Human, physical and intellectual resource generation: Proposals for monitoring, In: Murray CJL, Evans D, editors. Health systems performance assessment: Debates, methods and empiricism. Geneva: World Health Organization. Pp.273-287.
11. Lim YW, Steinhoff M, Girosi F, Holtzman D, Campbell H, et al. (2006) Reducing the global burden of acute lower respiratory infections in children: The contribution of new diagnostics Nature 444 (Suppl 1):9-18.
12. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, et al. (2007) Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: Randomised trial. BMJ 334:403.
13. Lubell Y, Reyburn H, Mdakilwa H, Mwangi R. Chonya S, ct al. (2008) The impact of response to the results of diagnostic tests for malaria: Cost-benefit analysis. BMJ 336: 202-205.
14. Scott I (2007) The evolving science of translating research evidence: info clinical practice. Evid Based Med 12: 4-7.
15. National Institutes for Health and Clinical Excellence (2004) Guide to the methods for technology appraisal. Available: http://www.nice.ofg.uk/ niceMedia/pdf/TAP-Methods.pdf. Accessed 3 November 2008.
16. Haddix A, Teutsch S. Corso P (2002) Prevention effectiveness: A guide to decision analysis and economic evaluation. Oxford: Oxford University Press.
17. Akumu AO, English M, Scott JA, Griffiths U (2007) Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bull World Health Organ 85: 51 1-518.
18. Elwyn G, Edwards A, Eccles M, Rovner D (2001) Decision analysis in patient care. Lancet 571-574.
19. World Health Organization (2002) World Health Report 2002: Reducing risks, promoting healthy life. Available: http://www.who.int./whr/2002/cn/. Accessed 3 November 2008.
20. Zurovac D, Rowe AK (2006) Quality of treatment for febrile illness among children al outpatient facilities in sub-Saharan Africa. Ann Trop Med Parasilot 100: 283-296.
21. Rowe A. de Savigny D. Lanata C, Victora C (2005) How can we achieve and maintain high quality performance of health workers in low resource settings? lancet 366: 1026-1035.
22. Kosek M, Bern C., Guerrant R (2003) The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 811: 197-204.
23. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H, WHO Child Health Epidemiology Reference Group (2004) Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 82: 895-903.
24. Snow R, Eckert E, Teklehaimanot A (2003) Estimating the needs for artesunate-based combination therapy for malaria ease management in Africa. Trends Parasitol 19: 363-369.